×
Health

Mylan CEO says brand competition doesn't drive drug prices down

Published Apr 27 2021 at 2:28 AM GMT
CBS News

CBS News @cbsnews.com

Continue reading at cbsnews.com
Key
Points
  • Heather Bresch, who was called before Congress last year to explain why EpiPen's price had soared by nearly 500 percent over seven years, tells Norah O'Donnell why a competing product on the market doesn't necessarily bring prices down.
Credit
Tags
Continue reading at cbsnews.com
Trending

Stats

  • Published Apr 27, 2021 2:28 AM GMT